Clinical Trial Update: EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye [Phase 3]

View source ↗

Summary

The EAGLE multicenter Phase 3 trial evaluating fibrinolytic therapy for retinal artery occlusion has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Artery Occlusion
• Stroke

Drugs mentioned

• Fibrinolytic therapy (thrombolytic agent)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Retinal Artery Occlusion, Fibrinolysis | Phase 3 | Status: TERMINATED